457 related articles for article (PubMed ID: 11502913)
21. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease.
Sakakibara R; Shinotoh H; Uchiyama T; Sakuma M; Kashiwado M; Yoshiyama M; Hattori T
Auton Neurosci; 2001 Sep; 92(1-2):76-85. PubMed ID: 11570707
[TBL] [Abstract][Full Text] [Related]
22. Excessive daytime sleepiness and subsequent development of Parkinson disease.
Abbott RD; Ross GW; White LR; Tanner CM; Masaki KH; Nelson JS; Curb JD; Petrovitch H
Neurology; 2005 Nov; 65(9):1442-6. PubMed ID: 16275833
[TBL] [Abstract][Full Text] [Related]
23. A survey of subjective constipation in Parkinson's disease patients in shanghai and literature review.
Gan J; Wan Y; Shi J; Zhou M; Lou Z; Liu Z
BMC Neurol; 2018 Mar; 18(1):29. PubMed ID: 29544459
[TBL] [Abstract][Full Text] [Related]
24. Medical records documentation of constipation preceding Parkinson disease: A case-control study.
Savica R; Carlin JM; Grossardt BR; Bower JH; Ahlskog JE; Maraganore DM; Bharucha AE; Rocca WA
Neurology; 2009 Nov; 73(21):1752-8. PubMed ID: 19933976
[TBL] [Abstract][Full Text] [Related]
25. Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study.
Benedetti MD; Bower JH; Maraganore DM; McDonnell SK; Peterson BJ; Ahlskog JE; Schaid DJ; Rocca WA
Neurology; 2000 Nov; 55(9):1350-8. PubMed ID: 11087780
[TBL] [Abstract][Full Text] [Related]
26. Constipation and risk of Parkinson's disease: A Danish population-based cohort study.
Svensson E; Henderson VW; Borghammer P; Horváth-Puhó E; Sørensen HT
Parkinsonism Relat Disord; 2016 Jul; 28():18-22. PubMed ID: 27234704
[TBL] [Abstract][Full Text] [Related]
27. Constipation and Cigarette Smoking Are Independent Influences for Parkinson's Disease.
Lehrer S; Rheinstein PH
Cureus; 2022 Jan; 14(1):e21689. PubMed ID: 35145822
[TBL] [Abstract][Full Text] [Related]
28. Coffee and tea consumption and the risk of Parkinson's disease.
Hu G; Bidel S; Jousilahti P; Antikainen R; Tuomilehto J
Mov Disord; 2007 Nov; 22(15):2242-8. PubMed ID: 17712848
[TBL] [Abstract][Full Text] [Related]
29. Association Between Parkinson's Disease and Inflammatory Bowel Disease: a Nationwide Taiwanese Retrospective Cohort Study.
Lin JC; Lin CS; Hsu CW; Lin CL; Kao CH
Inflamm Bowel Dis; 2016 May; 22(5):1049-55. PubMed ID: 26919462
[TBL] [Abstract][Full Text] [Related]
30. Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease.
Grandinetti A; Morens DM; Reed D; MacEachern D
Am J Epidemiol; 1994 Jun; 139(12):1129-38. PubMed ID: 8209872
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learned.
Parkinson Study Group. Electronic address: pfeiffro@ohsu.edu
Parkinsonism Relat Disord; 2017 Apr; 37():101-105. PubMed ID: 28237854
[TBL] [Abstract][Full Text] [Related]
32. Bowel movement and constipation frequencies and the risk of colorectal cancer among men in the Netherlands Cohort Study on Diet and Cancer.
Simons CC; Schouten LJ; Weijenberg MP; Goldbohm RA; van den Brandt PA
Am J Epidemiol; 2010 Dec; 172(12):1404-14. PubMed ID: 20980354
[TBL] [Abstract][Full Text] [Related]
33. Constipation and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.
Tashiro N; Budhathoki S; Ohnaka K; Toyomura K; Kono S; Ueki T; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Terasaka R
Asian Pac J Cancer Prev; 2011; 12(8):2025-30. PubMed ID: 22292645
[TBL] [Abstract][Full Text] [Related]
34. Differences in Parkinson's Disease Risk with Caffeine Intake and Postmenopausal Hormone Use.
Kim IY; O'Reilly ÉJ; Hughes KC; Gao X; Schwarzschild MA; Ascherio A
J Parkinsons Dis; 2017; 7(4):677-684. PubMed ID: 28984617
[TBL] [Abstract][Full Text] [Related]
35. Survival of Parkinson's disease patients in a large prospective cohort of male health professionals.
Chen H; Zhang SM; Schwarzschild MA; Hernán MA; Ascherio A
Mov Disord; 2006 Jul; 21(7):1002-7. PubMed ID: 16602107
[TBL] [Abstract][Full Text] [Related]
36. The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria.
Mishima T; Fukae J; Fujioka S; Inoue K; Tsuboi Y
J Parkinsons Dis; 2017; 7(2):353-357. PubMed ID: 28157108
[TBL] [Abstract][Full Text] [Related]
37. Dietary intake of antioxidant vitamins and risk of Parkinson's disease: a case-control study in Japan.
Miyake Y; Fukushima W; Tanaka K; Sasaki S; Kiyohara C; Tsuboi Y; Yamada T; Oeda T; Miki T; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
Eur J Neurol; 2011 Jan; 18(1):106-13. PubMed ID: 20491891
[TBL] [Abstract][Full Text] [Related]
38. Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study.
Zangaglia R; Martignoni E; Glorioso M; Ossola M; Riboldazzi G; Calandrella D; Brunetti G; Pacchetti C
Mov Disord; 2007 Jul; 22(9):1239-44. PubMed ID: 17566120
[TBL] [Abstract][Full Text] [Related]
39. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study.
Taylor CA; Saint-Hilaire MH; Cupples LA; Thomas CA; Burchard AE; Feldman RG; Myers RH
Am J Med Genet; 1999 Dec; 88(6):742-9. PubMed ID: 10581500
[TBL] [Abstract][Full Text] [Related]
40. Prospective study of coffee consumption and risk of Parkinson's disease.
Sääksjärvi K; Knekt P; Rissanen H; Laaksonen MA; Reunanen A; Männistö S
Eur J Clin Nutr; 2008 Jul; 62(7):908-15. PubMed ID: 17522612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
